BioDelivery Sciences International completes acquisition of Elyxyb for acute migraine treatment in the U.S. and Canada
BioDelivery Sciences International, Inc. a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced that it has completed the acquisition of U.S. and Canadian rights… read more.
